Vicore Pharma Holding AB (publ) (FRA:6Y4)
1.134
-0.002 (-0.18%)
Last updated: Jan 28, 2026, 8:23 AM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 760.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 8.50M, down -91.85% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
8.50M SEK
Revenue Growth
-91.85%
P/S Ratio
387.85
Revenue / Employee
236.14K SEK
Employees
36
Market Cap
298.23M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allane SE | 827.69M |
| SIMONA Aktiengesellschaft | 586.42M |
| centrotherm international AG | 288.81M |
| Eleving Group | 203.19M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 171.37M |
| Novabase S.G.P.S. | 130.35M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |